Announced details
Promoting understanding of gene-related treatments and testing, and expanding support for the company's approach
Joint operation
Head office: Minato-ku, Tokyo; Representative Director: Takeda Takashi (武田 隆)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | つながる遺伝子ラボ Gene+Connect |
| Counterparty | クオン株式会社 |
| Counterparty overview | Head office: Minato-ku, Tokyo; Representative Director: Takeda Takashi (武田 隆) |
| Relationship with the Company | Joint operation |
| Applicable area | Promoting understanding of gene-related treatments and testing, and expanding support for the company's approach |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The companies state that the platform has achieved a certain level of progress and will be brought to a close as they move forward with new initiatives aimed at its next stage of development.